Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: eryaspase (L-asparaginase encapsulated in red blood cells)|DRUG: Gemcitabine|DRUG: Carboplatin
Sponsor: ERYtech Pharma